SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $328,000 | -81.0% | 1,900 | -87.3% | 0.00% | -75.0% |
| Q4 2014 | $1,724,000 | -27.2% | 15,000 | -1.0% | 0.00% | -20.0% |
| Q3 2014 | $2,367,000 | +26.6% | 15,148 | 0.0% | 0.01% | +25.0% |
| Q2 2014 | $1,869,000 | -3.3% | 15,148 | -18.8% | 0.00% | +33.3% |
| Q1 2014 | $1,933,000 | +1.7% | 18,660 | -11.7% | 0.00% | 0.0% |
| Q4 2013 | $1,901,000 | +3.8% | 21,139 | -22.8% | 0.00% | -25.0% |
| Q3 2013 | $1,831,000 | -75.9% | 27,380 | -76.2% | 0.00% | -76.5% |
| Q2 2013 | $7,599,000 | – | 114,882 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |